The biotech said it would use the cash to “further accelerate” a portfolio led by its GLP-1 receptor agonist MET-097, which ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

"We've seen firsthand how transformative GLP-1 treatments like semaglutide can be for patients' lives. We remain focused on ...

Obesity is a chronic condition and a key risk factor for a range of other health issues, including type 2 diabetes. In a ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

The Hormone Diet emphasizes anti-inflammatory foods to help you balance hormones like cortisol and estrogen and lose weight.

This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

As a beauty journalist, I can offer recommendations for the best mascaras without skipping a beat. Struggling with melasma? I ...

Powers Health surgical and medical ... their weight loss and overall health. For those who aren’t candidates for surgery or prefer nonsurgical options, we also offer GLP-1 receptor agonists ...

Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye"), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health ...